These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24506005)

  • 1. Prevalence of hepatitis B infection in rheumatoid arthritis patients.
    Alishiri GH; Ghorbani GA; Ahmad S
    Pak J Biol Sci; 2013 Aug; 16(15):747-50. PubMed ID: 24506005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM; Chen HH; Huang WN; Chen YH; Hsieh TY; Yang SS; Lan JL; Chen DY
    Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Tien YC; Yen HH; Chiu YM
    Clin Exp Rheumatol; 2017; 35(5):831-836. PubMed ID: 28375829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Nakamura J; Nagashima T; Nagatani K; Yoshio T; Iwamoto M; Minota S
    Int J Rheum Dis; 2016 May; 19(5):470-5. PubMed ID: 24698305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
    Fujita M; Sugiyama M; Sato Y; Nagashima K; Takahashi S; Mizokami M; Hata A
    J Viral Hepat; 2018 Nov; 25(11):1312-1320. PubMed ID: 29770539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
    Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
    Chiu YM; Lai MS; Chan KA
    PLoS One; 2018; 13(4):e0196210. PubMed ID: 29694398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
    Laohapand C; Arromdee E; Tanwandee T
    Hepatol Int; 2015 Apr; 9(2):202-8. PubMed ID: 25788188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Watanabe T; Fukae J; Fukaya S; Sawamukai N; Isobe M; Matsuhashi M; Shimizu M; Akikawa K; Tanimura K; Atsumi T; Koike T
    Int J Rheum Dis; 2019 Apr; 22(4):574-582. PubMed ID: 30338649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
    Ahn SS; Jung SM; Song JJ; Park YB; Park JY; Lee SW
    Yonsei Med J; 2018 May; 59(3):452-456. PubMed ID: 29611409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Ann Rheum Dis; 2017 Jun; 76(6):1051-1056. PubMed ID: 27934678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.